Regulatory

>

Latest News

Asembia 2025: A General Landscape of the Pharmaceutical Industry
Asembia 2025: A General Landscape of the Pharmaceutical Industry

April 29th 2025

IQVIA’s Doug Long offers a lay of the land, including trends and developing issues that are shaping the current market.

FDA Approves Akeso’s PD-1 Monoclonal Antibody for Recurrent or Metastatic Non-Keratinizing Nasopharyngeal Carcinoma
FDA Approves Akeso’s PD-1 Monoclonal Antibody for Recurrent or Metastatic Non-Keratinizing Nasopharyngeal Carcinoma

April 25th 2025

Bill Coyle
Predicting and Planning for Tariff Impacts: Q&A with Bill Coyle

April 25th 2025

AbbVie Submits Biologics License Application to FDA for Novel Serotype E Botulinum Neurotoxin in Moderate to Severe Glabellar Lines
AbbVie Submits Biologics License Application to FDA for Novel Serotype E Botulinum Neurotoxin in Moderate to Severe Glabellar Lines

April 24th 2025

FDA Updates Prescribing Information for Bristol Myers Squibb’s Camzyos to Reduce Echocardiography Monitoring Requirements
FDA Updates Prescribing Information for Bristol Myers Squibb’s Camzyos to Reduce Echocardiography Monitoring Requirements

April 21st 2025

More News